Misplaced Pages

Draft:Avoiding immune destruction: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editContent deleted Content addedVisualWikitext
Revision as of 02:51, 16 December 2024 editRA0808 (talk | contribs)Extended confirmed users, New page reviewers, Pending changes reviewers, Rollbackers100,211 editsm Removing CSD template← Previous edit Latest revision as of 02:55, 16 December 2024 edit undoJJMC89 bot (talk | contribs)Bots1,161,657 editsm Add {{drafts moved from mainspace}} 
Line 26: Line 26:


* The extracellular matrix, cytokines, chemokines, and other cell types that make up the tumor microenvironment can all be modified by cancer cells. * The extracellular matrix, cytokines, chemokines, and other cell types that make up the tumor microenvironment can all be modified by cancer cells.

{{Drafts moved from mainspace|date=December 2024}}

Latest revision as of 02:55, 16 December 2024

Avoiding Immune Destruction



Mechanisms

Many strategies exist for cancer cells to evade immune destruction, such as:

1) Immune mimicry

  • Myeloid-derived cells are immune cells that stimulate other immune system components, and cancer cells can mimic their actions. As a result, cancer cells are able to avoid the negative effects of inflammation.


2) Hijacking the PD-1/PDL-1 mechanism

  • T lymphocytes are rendered inactive by PD-L1, a ligand that binds to PD-1 on their surface and is produced by cancer cells.


3) Modulating immune checkpoints

  • To avoid being discovered and eliminated, cancer cells can take use of immunological checkpoints, which are the immune system's natural regulatory systems.


4) Altering the tumor microenvironment

  • The extracellular matrix, cytokines, chemokines, and other cell types that make up the tumor microenvironment can all be modified by cancer cells.